ASC Therapeutics
PrivateCompany Overview
ASC Therapeutics is a biotechnology company that develops gene replacement, gene editing, and allogeneic cell therapies for hematological, metabolic, and other rare diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ASC Therapeutics Comparables
Compare ASC Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sangamo Therapeutics Inc | 83% | |
| Expression Therapeutics, Inc. | 81% | |
| Ultragenyx Pharmaceutical Inc. | 79% |
ASC Therapeutics Funding Rounds
Historical fundraising activity
ASC Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ASC Therapeutics's valuation, stock price, and market status.
Is ASC Therapeutics a public or private company?
ASC Therapeutics is a private company.
What is the current stock price of ASC Therapeutics?
ASC Therapeutics is a private company with no public stock price. Caplight tracks ASC Therapeutics's secondary market activity and provides MarketPrice estimates to Caplight users.
How much is ASC Therapeutics worth (valuation)?
Valuation information for ASC Therapeutics is not publicly available.
Can I buy ASC Therapeutics stock?
ASC Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ASC Therapeutics's last funding round?
Funding round information for ASC Therapeutics is not publicly available.
Who are the main investors in ASC Therapeutics?
Investor information for ASC Therapeutics is not publicly disclosed.
Will ASC Therapeutics IPO soon?
No public IPO plans have been announced for ASC Therapeutics.
How can I track ASC Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ASC Therapeutics's secondary market activity and sign up for updates.